475 related articles for article (PubMed ID: 35356147)
1. Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans.
Calvert L; Green MP; De Iuliis GN; Dun MD; Turner BD; Clarke BO; Eamens AL; Roman SD; Nixon B
Front Endocrinol (Lausanne); 2021; 12():799043. PubMed ID: 35356147
[TBL] [Abstract][Full Text] [Related]
2. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.
Ding N; Harlow SD; Randolph JF; Loch-Caruso R; Park SK
Hum Reprod Update; 2020 Sep; 26(5):724-752. PubMed ID: 32476019
[TBL] [Abstract][Full Text] [Related]
3. Maternal Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Male Reproductive Function in Young Adulthood: Combined Exposure to Seven PFAS.
Hærvig KK; Petersen KU; Hougaard KS; Lindh C; Ramlau-Hansen CH; Toft G; Giwercman A; Høyer BB; Flachs EM; Bonde JP; Tøttenborg SS
Environ Health Perspect; 2022 Oct; 130(10):107001. PubMed ID: 36197086
[TBL] [Abstract][Full Text] [Related]
4. Per- and polyfluoroalkyl substances and male reproductive health: a systematic review of the epidemiological evidence.
Petersen KU; Larsen JR; Deen L; Flachs EM; Hærvig KK; Hull SD; Bonde JPE; Tøttenborg SS
J Toxicol Environ Health B Crit Rev; 2020 Aug; 23(6):276-291. PubMed ID: 32741292
[TBL] [Abstract][Full Text] [Related]
5. Toxic effects of per- and polyfluoroalkyl substances on sperm: Epidemiological and experimental evidence.
Sun Z; Wen Y; Wang B; Deng S; Zhang F; Fu Z; Yuan Y; Zhang D
Front Endocrinol (Lausanne); 2023; 14():1114463. PubMed ID: 36891048
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity assessment of perfluoroalkyl substances on human sperm.
Emerce E; Çetin Ö
Toxicol Ind Health; 2018 Dec; 34(12):884-890. PubMed ID: 30326792
[TBL] [Abstract][Full Text] [Related]
7. Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk.
Roth K; Petriello MC
Front Endocrinol (Lausanne); 2022; 13():965384. PubMed ID: 35992116
[TBL] [Abstract][Full Text] [Related]
8. Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review.
Bach CC; Vested A; Jørgensen KT; Bonde JP; Henriksen TB; Toft G
Crit Rev Toxicol; 2016 Oct; 46(9):735-55. PubMed ID: 27268162
[TBL] [Abstract][Full Text] [Related]
9. Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease.
Rickard BP; Rizvi I; Fenton SE
Toxicology; 2022 Jan; 465():153031. PubMed ID: 34774661
[TBL] [Abstract][Full Text] [Related]
10. Systematic Evidence Map for Over One Hundred and Fifty Per- and Polyfluoroalkyl Substances (PFAS).
Carlson LM; Angrish M; Shirke AV; Radke EG; Schulz B; Kraft A; Judson R; Patlewicz G; Blain R; Lin C; Vetter N; Lemeris C; Hartman P; Hubbard H; Arzuaga X; Davis A; Dishaw LV; Druwe IL; Hollinger H; Jones R; Kaiser JP; Lizarraga L; Noyes PD; Taylor M; Shapiro AJ; Williams AJ; Thayer KA
Environ Health Perspect; 2022 May; 130(5):56001. PubMed ID: 35580034
[TBL] [Abstract][Full Text] [Related]
11. Per- and polyfluoroalkyl substances exposure and its influence on the intestinal barrier: An overview on the advances.
Li J; Wang L; Zhang X; Liu P; Deji Z; Xing Y; Zhou Y; Lin X; Huang Z
Sci Total Environ; 2022 Dec; 852():158362. PubMed ID: 36055502
[TBL] [Abstract][Full Text] [Related]
12. Perfluoroalkyl/Polyfluoroalkyl Substances: Links to Cardiovascular Disease Risk.
Schlezinger JJ; Gokce N
Circ Res; 2024 Apr; 134(9):1136-1159. PubMed ID: 38662859
[TBL] [Abstract][Full Text] [Related]
13. Dietary intake, drinking water ingestion and plasma perfluoroalkyl substances concentration in reproductive aged Chinese women.
Zhou W; Zhao S; Tong C; Chen L; Yu X; Yuan T; Aimuzi R; Luo F; Tian Y; Zhang J;
Environ Int; 2019 Jun; 127():487-494. PubMed ID: 30981019
[TBL] [Abstract][Full Text] [Related]
14. Assessing the human health risks of per- and polyfluoroalkyl substances: A need for greater focus on their interactions as mixtures.
Ojo AF; Peng C; Ng JC
J Hazard Mater; 2021 Apr; 407():124863. PubMed ID: 33373965
[TBL] [Abstract][Full Text] [Related]
15. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.
Fenton SE; Ducatman A; Boobis A; DeWitt JC; Lau C; Ng C; Smith JS; Roberts SM
Environ Toxicol Chem; 2021 Mar; 40(3):606-630. PubMed ID: 33017053
[TBL] [Abstract][Full Text] [Related]
16. Expanded Systematic Evidence Map for Hundreds of Per- and Polyfluoroalkyl Substances (PFAS) and Comprehensive PFAS Human Health Dashboard.
Shirke AV; Radke EG; Lin C; Blain R; Vetter N; Lemeris C; Hartman P; Hubbard H; Angrish M; Arzuaga X; Congleton J; Davis A; Dishaw LV; Jones R; Judson R; Kaiser JP; Kraft A; Lizarraga L; Noyes PD; Patlewicz G; Taylor M; Williams AJ; Thayer KA; Carlson LM
Environ Health Perspect; 2024 Feb; 132(2):26001. PubMed ID: 38319881
[TBL] [Abstract][Full Text] [Related]
17. Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.
Brase RA; Mullin EJ; Spink DC
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498193
[TBL] [Abstract][Full Text] [Related]
18. Dietary exposure to per- and polyfluoroalkyl substances: Potential health impacts on human liver.
Zhang J; Hu L; Xu H
Sci Total Environ; 2024 Jan; 907():167945. PubMed ID: 37871818
[TBL] [Abstract][Full Text] [Related]
19. The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS).
Solan ME; Lavado R
J Appl Toxicol; 2022 Aug; 42(8):1298-1309. PubMed ID: 34873727
[TBL] [Abstract][Full Text] [Related]
20. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects.
Blake BE; Fenton SE
Toxicology; 2020 Oct; 443():152565. PubMed ID: 32861749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
